Indivior Pharmaceuticals (INDV) Return on Invested Capital (2024 - 2026)

Indivior Pharmaceuticals' Return on Invested Capital history runs 3 years deep, the most recent figure standing at 0.03% for Q1 2026.

• In Q1 2026, Return on Invested Capital fell 3.0% year-over-year to 0.03%; the TTM figure through Mar 2026 stood at 0.03% (down 3.0% YoY), while the FY2025 annual figure was 0.06%, down 7.0% from the prior year.
• Return on Invested Capital was 0.03% for Q1 2026 at Indivior Pharmaceuticals, down from 0.02% in the prior quarter.
• In the past five years, Return on Invested Capital ranged from a high of 0.0% in Q1 2025 to a low of 0.03% in Q1 2026.
• Historically, Return on Invested Capital has averaged 0.01% across 3 years, with a median of 0.01% in 2025.
• The sharpest annual moves came in 2025 and 2026: Return on Invested Capital fell 2 bps in 2025, then fell 3 bps in 2026.
• A 3-year view of Return on Invested Capital shows it stood at 0.0% in 2024, then plunged by 2007 bps to 0.02% in 2025, then plunged by 49 bps to 0.03% in 2026.
• The last three Return on Invested Capital figures came in at 0.03% (Q1 2026), 0.02% (Q4 2025), and 0.01% (Q3 2025), per Business Quant data.